Earnings Feed
Start Free
MYRIAD GENETICS INC·4

Jun 8, 5:30 PM ET

HOBDEN ADRIAN N 4

4 · MYRIAD GENETICS INC · Filed Jun 8, 2009

Insider Transaction Report

Form 4
Period: 2009-06-08
MYRIAD GENETICS INCMYGN
HOBDEN ADRIAN N
Pres. Myriad Pharmaceuticals
Transactions
  • Exercise/Conversion

    Common Stock

    2009-06-08$10.28/sh+29,178$299,950→ 234,071 total
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2009-06-08−29,178→ 9,726 total
    Exercise: $10.28Exp: 2015-09-14→ Common Stock (29,178 underlying)
  • Exercise/Conversion

    Common Stock

    2009-06-08$12.53/sh+7,980$100,000→ 204,893 total
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2009-06-08−7,980→ 0 total
    Exercise: $12.53Exp: 2010-04-20→ Common Stock (7,980 underlying)
Footnotes (2)
  • [F1]The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.
  • [F2]20% vests annually beginning on the 1st anniversary of the date of the Option Grant.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT